(VIANEWS) – Shares of 10x Genomics (NASDAQ Composite: TXG) slid 6.57% to $149.74 at 17:26 EST on Wednesday, following the last session’s downward trend. NASDAQ Composite is rising 0.45% to $15,993.71, after two sequential sessions in a row of losses. This seems, up to now, a somewhat positive trend exchanging session today.
10x Genomics’s last close was $160.27, 23.31% below its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 645903 which is 5.79% above its average volume of 610529.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $149.74 at 17:26 EST, way below its 52-week high of $208.99 and way higher than its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s value is below its 50-day moving average of $158.46 and way under its 200-day moving average of $171.28.
More news about 10x Genomics (TXG).